20
Covalent Laboratories Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is CEFPROZIL USP, with a corresponding US DMF Number 29383.
Remarkably, this DMF maintains an Active status since its submission on May 15, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 11, 2017, and payment made on May 31, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II